During the past decade, Ferrer Internacional S.A. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ferrer Internacional S.A." are "Agitation" (1 trials) and "Vulvovaginal Candidiasis" (1 trials). Many other conditions were trialed in "Ferrer Internacional S.A." in a lesser frequency.

Most popular intervention types in "Ferrer Internacional S.A." are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Staccato® Delivery System Loxapine (ADASUVE®)" (1 trials), "arasertaconazole nitrate" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ferrer Internacional S.A." are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ferrer Internacional S.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ferrer Internacional S.A., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ferrer Internacional S.A., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".